Equity award lifts Xylem (NYSE: XYL) director holdings to 10,406 shares

Rhea-AI Filing Summary

Tretikov Lila reported acquisition or exercise transactions in this Form 4 filing.

Xylem Inc. director Lila Tretikov received an equity award of 1,711 shares of common stock in the form of restricted stock units valued at $116.88 per share. These units are scheduled to vest in full on the trading day before the 2027 Annual Meeting of Shareholders, bringing her direct holdings to 10,406 shares including those added through dividend reinvestment.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Tretikov Lila

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,711	$116.88	$200K

Holdings After Transaction: Common Stock — 10,406 shares (Direct, null)

Footnotes (1)

1. Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. Includes additional shares due to dividend reinvestment.

Key Figures

Restricted stock units granted: 1,711 shares Grant price per share: $116.88 per share Shares held after transaction: 10,406 shares

3 metrics

Restricted stock units granted 1,711 shares Equity award to director Lila Tretikov

Grant price per share $116.88 per share Value assigned to restricted stock unit award

Shares held after transaction 10,406 shares Direct holdings following RSU grant, including dividend reinvestment

Key Terms

restricted stock units, dividend reinvestment, Omnibus Incentive Plan, Annual Meeting of Shareholders

4 terms

restricted stock units financial

"Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

dividend reinvestment financial

"Includes additional shares due to dividend reinvestment."

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

Omnibus Incentive Plan financial

"pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016)"

An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.

Annual Meeting of Shareholders financial

"scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders."

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tretikov Lila

(Last) (First) (Middle)

C/O XYLEM INC.

301 WATER STREET SE

(Street)

WASHINGTON DISTRICT OF COLUMBIA 20003

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Xylem Inc. [ XYL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/14/2026		A		1,711(1)	A	$116.88	10,406(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders.

2. Includes additional shares due to dividend reinvestment.

	/s/ Mike Nazario, by power of attorney for Lila Tretikov	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did the latest Xylem (XYL) Form 4 filing report for Lila Tretikov?

The filing shows director Lila Tretikov received an award of 1,711 restricted stock units of Xylem common stock at $116.88 per share. This is a compensation-related grant, not an open-market purchase, and increases her direct holdings to 10,406 shares including dividend reinvestment.

How many Xylem (XYL) shares does Lila Tretikov hold after this Form 4 transaction?

After the transaction, Lila Tretikov directly holds 10,406 shares of Xylem common stock. This total includes the newly granted 1,711 restricted stock units and additional shares credited through dividend reinvestment, as disclosed in the Form 4 footnotes for this equity award.

What type of transaction was reported for Xylem (XYL) director Lila Tretikov?

The transaction was coded “A” for a grant, award, or other acquisition of Xylem common stock. It reflects restricted stock units granted under the Xylem 2011 Omnibus Incentive Plan, rather than an open-market buy or sell, and is categorized as an acquisition event.

When will Lila Tretikov’s new Xylem (XYL) restricted stock units vest?

The 1,711 restricted stock units are scheduled to vest in full on the trading day prior to Xylem’s 2027 Annual Meeting of Shareholders. Vesting timing is tied to that meeting date, aligning the award with the company’s long-term governance and performance cycle.

Were Lila Tretikov’s Xylem (XYL) holdings affected by dividend reinvestment?

Yes. The Form 4 footnotes state that her reported total includes additional shares due to dividend reinvestment. This means some of the 10,406 Xylem shares were accumulated automatically when cash dividends were reinvested into additional common stock over time.